WhatWeDo - Specialised Therapeutics

STA successfully launches and manages Named Patient Access Programs in our regions, enabling patients early or compassionate access to new therapies.

Our experienced teams navigate reimbursement applications and processes for pharmaceutical products, companion diagnostics and other medical technologies.

STA achieves rapid market penetration and leadership of portfolio therapies.

STA regulatory teams manage complex submission processes in all key markets, including Orphan and Fast-Track designations.

STA is open to joint ventures, typical royalty and milestone-based licensing agreements or other creative, mutually beneficial partnering opportunities.